title: Gefitinib for refractory advanced non-small-cell lung cancer.
authors.forename: Junji
authors.initials: J
authors.lastname: Tsurutani
authors.forename: Marc
authors.initials: M
authors.lastname: Ballas
authors.forename: Seth M
authors.initials: SM
authors.lastname: Steinberg
authors.forename: Valgardur
authors.initials: V
authors.lastname: Egilsson
authors.forename: Phillip A
authors.initials: PA
authors.lastname: Dennis
mesh_terms: D002282:Adenocarcinoma, Bronchiolo-Alveolar / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D000069347:Erlotinib Hydrochloride; D005260:Female; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*; D012907:Smoking / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D000077156:Gefitinib